(Q44658955)

English

Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover

scientific article published on November 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

0 references

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

author name string

Hirokazu Uemura

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Toshiyuki Yasui

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yuka Umino

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hirobumi Niki

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Masaya Takikawa

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Seiichiro Saito

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hiroyuki Furumoto

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Minoru Irahara

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14623063

3 April 2024

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S8756328203002837?httpAccept=text/xml

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

https://api.elsevier.com/content/article/PII:S8756328203002837?httpAccept=text/plain

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

860-866

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Treatment of postmenopausal osteoporosis with transdermal estrogen

1

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

3

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

4

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

5

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

6

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Combination of automatic HPLC-RIA method for determination of estrone and estradiol in serum

7

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass

8

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

The role of GnRH agonists plus add-back therapy in the treatment of endometriosis

10

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss

11

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

The relative contributions of age and years since menopause to postmenopausal bone loss.

12

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Skeletal effects of estrogen

13

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

14

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

15

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism

16

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Increased osteoclast development after estrogen loss: mediation by interleukin-6

18

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Mice Lacking the Type I Interleukin-1 Receptor Do Not Lose Bone Mass after Ovariectomy

19

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency

20

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Estrogen deficiency increases the ability of stromal cells to support murine osteoclastogenesis via an interleukin-1and tumor necrosis factor-mediated stimulation of macrophage colony-stimulating factor production

21

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor

22

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women

24

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

25

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology

28

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

The effect of a single dose of osteoprotegerin in postmenopausal women

29

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption

30

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease

31

1 reference

10.1016/J.BONE.2003.08.001

https://api.crossref.org/works/10.1016/J.BONE.2003.08.001

3 April 2024

Identifiers

10.1016/J.BONE.2003.08.001

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44658955&oldid=2117916328"